Lilly obesity-pill trial results find a warmer reception on Wall Street this time around
Up next
Author


Pharmaceutical giant Eli Lilly said it will now move “with urgency” toward getting regulatory approval for orforglipron.

You May Also Like
Opinion: How to help American families afford child care? Boost the child tax credit

Opinion: How to help American families afford child care? Boost the child tax credit

“If many mothers value being at home more than a paycheck, then…
DuPont brings a twist to its spinoff plans

DuPont brings a twist to its spinoff plans

The chemicals giant said late Wednesday that it would keep its water-filtration…

Nvidia and iPhone maker Foxconn tie up on ‘AI factories’

Nvidia and iPhone maker Foxconn have said they will build “artificial intelligence…
Oil prices consolidate as investors weigh China demand

Oil prices consolidate as investors weigh China demand

Oil futures hovered near unchanged early Tuesday, consolidating after a pullback the…